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Abstract
Background:The aim of this study was to summarize current evidence evaluating the association between antenatal infection and
intraventricular hemorrhage (IVH) in preterm infants.
Materials andmethods:We searched for published articles on antenatal infection and IVH in 3 English (PubMed, the Cochrane
Library, and EBSCO) and 3 Chinese (VEIPU, CNKI, andWANFANG) databases on May 19, 2019. In addition, the references of these
articles were screened. The included studies had to meet all of the following criteria: preterm infants (<37 weeks); comparing
antenatal infection with no infection; the outcomes included IVH (all grades), mild IVH, or sereve IVH; the type of study was
randomized controlled trial or cohort study.
Results:A total of 23 cohort studies involving 13,605 preterm infants met our inclusion criteria. Antenatal infection increased the risk
of IVH (odds ratios ([OR] 2.18, 95% conﬁdence intervals [CI] 1.58–2.99), mild IVH (OR 1.95, 95% CI 1.09–3.49) and severe IVH (OR
2.65, 95% CI 1.52–4.61). For type of antenatal infection, the ORs and 95%CI were as follows: 2.21 (1.60–3.05) for chorioamnionitis,
2.26 (1.55–3.28) for histologic chorioamnionitis, 1.88 (1.22–2.92) for clinical chorioamnionitis, and 1.88 (1.14–3.10) for ureaplasma.
Conclusions: Antenatal infection may increase the risk of developing IVH in the preterm infant. The evidence base is however of
low quality and well-designed studies are needed.
Abbreviations: CI = conﬁdence intervals, GA = Gestational age, IVH = Intraventricular hemorrhage, NOS = Newcastle-Ottawa
Scale, OR = odds ratios, RCT = Randomized controlled trial.
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Preterm birth is the leading cause of neonatal death and under-
ﬁve mortality worldwide.[1] Intraventricular hemorrhage (IVH),
one of most common complication of preterm birth, is a majorEditor: María–Luz Couce.
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1risk factor for death and neurodevelopmental disabilities in
preterm infants.[2] Despite the improvement of neonatal intensive
care in the last few decades, the morbidity of IVH has not
declined, mainly because of a signiﬁcant increase in survival rates
of premature neonates.[3] The incidence of IVH ranges from 25%
to 45% in preterm infants weighing<1500g.[3–5] Mortality rates
were 4%, 10%, 18%, and 40%, respectively, for grades I, II, III,
and IV IVH during initial hospitalization.[6] Among survivors,
both mild (grade I and II) and severe IVH (grade III and IV) are
associated with high risk of moderate–severe neurodevelopmen-
tal impairment.[2,3] Average hospital cost per infants has also
increased from $201,578 to $353,554 in the past decade, which
places a tremendous burden on affected families.[6] Currently, the
risk factors for IVH are not completely clear. Established risk
factors include small gestational age (GA) and low birth weight
(LBW).[7]
Antenatal infection has been reported to be an important risk
factor for preterm delivery. It is responsible for 40%of premature
deliveries.[8] Recent research indicates that exposure to intra-
uterine infection/inﬂammation results in more serious injury than
preterm delivery alone. It is associated with complications
including neonatal sepsis,[9] bronchopulmonary dysplasia, and
patent ductus arteriosus.[10,11]
A relationship between antenatal infection and IVH has been
widely supported by pathophysiological mechanism from
scientiﬁc research. It involves interactions between strong
immunological reactions and inﬂammatory cascades.[12–14]
Previous studies have suggested that inﬂammatory factors may
Huang et al. Medicine (2019) 98:31 Medicineultimately lead to the occurrence of IVH through elevation of
cerebral oxygen consumption,[15–18] breakdown of the brain
barriers,[19] and activation of the immune response.[20] Besides
the effects of inﬂammatory factors, the unstable blood pressure of
the brain by infection may also contribute to the development of
IVH. Premature infants lack mature autoregulation function of
cerebral blood pressure.[21] Infection and sepsis may induce
abnormal ﬂuctuations of blood pressure, resulting in unstable
cerebral blood pressure, leading to an increase in the risk of
IVH.[22] Recently, clinical studies have reported a relationship
between antenatal infection and IVH.[18,23] To date, there has
been no systematic review regarding the relationship between
antenatal infection and IVH. Thus, we systematically reviewed
the current evidence evaluating the effects of antenatal infection
on the risk of IVH in preterm infants.2. Material and methods
2.1. Search strategy
We searched for published articles on antenatal infection and
IVH in 3 English (PubMed, the Cochrane Library, and EBSCO)
and three Chinese (VEIPU, CNKI, and WANFANG) databases
on May 19, 2019. In addition, the references of the included
studies were also screened.We used the keywords (“preterm”OR
“premature”) AND (“chorioamnionitis” OR “infection”
OR “inﬂammation” OR “amnionitis” OR “amnionitides” OR
“funisitis” OR “funisitides” OR “sepsis” OR “pyemia” OR
“pyohemia” OR “pyaemia” OR “septicemia” OR “poisoning,
blood”OR “blood poisoning”) AND (“cerebral intraventricular
hemorrhages” OR “hemorrhage, cerebral intraventricular” OR
“intraventricular hemorrhage, cerebral” OR “cerebral intraven-
tricular haemorrhage” OR “haemorrhage, cerebral intraventric-
ular”OR “intraventricular haemorrhage, cerebral”) to search for
and select studies including the target population.
2.2. Study selection
Two researchers (JLH and JJM) independently searched for and
screened all the citations identiﬁed by the above searches by
reviewing their titles and abstracts. Then, the full texts of the
relevant studies were retrieved. The included studies had to meet
all of the following criteria: preterm infants (<37 weeks);
comparing antenatal infection with no infection; the outcomes
included IVH (all grades), mild IVH, or severe IVH; the type of
study was randomized controlled trial (RCT) or cohort study.
We excluded case–control studies, cross-section studies, case
reports, commentary articles, editorials, and animal research.2.3. Data extraction
Two investigators (JLH and JJM) performed separate data
extractions using a structured data extraction sheet. The following
data were extracted from each study: authors, year of publication,
country, studydesign,GA, birthweight, IVHgrade, infection type,
and number of participants. Studies approved by both inves-
tigators were included in the meta-analysis.2.4. Quality assessment
For RCTs, we would use the criteria outlined in the Cochrane
Handbook for Systematic Reviews of interventions.[24,25]
However, no RCTs were identiﬁed. The quality of observational2studies was assessed by the Newcastle-Ottawa Scale (NOS).[26,27]
NOS involves the 2 investigators rating the studies by scores for
the quality of the studies’ study group selection, study group
comparability, and ability to assess the outcome of interest.[27]
Studies were divided into high-quality (scores of 9) and low-
quality (scores of 1–8).[26] Any discrepancies regarding study
quality were discussed and resolved by a third author.2.5. GRADE assessment
A “Summary of ﬁnding” table was prepared to evaluate the
quality of the evidence. Observational studies were graded as
low-certainty evidence. The quality was downgraded if there
were limitations, inconsistencies, indirectness, imprecision and
other considerations, or upgraded to high and moderate if there
was large effect or a dose–response gradient.2.6. Statistical analysis
We conducted the statistical analyses with Cochrane Collabo-
ration’s Review manager 5.3 (Cochrane Collaboration, UK) and
Stata 12.0 (StataCorp, College Station, Texas). The associations
between antenatal infection and IVH were expressed as odds
ratios (OR) with corresponding 95% conﬁdence intervals (CI).
Between-study statistical heterogeneity was assessed using the Q
statistic (signiﬁcant at P< .1) and I2 values (values of 25%, 50%,
and 75% represented low, moderate, and high heterogeneity,
respectively). The random-effects model was selected when the I2
≥50% or P< .1, otherwise, the ﬁxed-effects model was used.
We conducted sensitivity analysis by: removing low-quality
studies; removing the baseline imbalance studies in GA (the P
value< .05 or without P value among groups), and re-analyzing
the remaining studies, to assess the stability of the results. And we
evaluated the subgroups to explore the possible heterogeneity
and the I2 and P value were used to represent subgroup
difference. Then, we performed funnel plots and Egger test to
assess publication bias in each of the pooled study groups when
≥5 included studies were available.[28]3. Results
3.1. Study characteristics
We identiﬁed 3688 publications published between each data-
base’s date of inception and May 19, 2019. We excluded 302
duplicate studies. A total of 3349 of the above studies were
excluded by title and abstract. We subjected the remaining 39
studies to a full-text review. Fifteen studies were excluded as there
was no relevant comparison and 1 study was excluded as it was a
review. Ultimately, we pooled data from 23 studies involving
13,605 preterm infants[18,23,29–49] for the meta-analysis (Fig. 1).
The majority of studies were published after 2000. The sample
size of included studies ranges from 62 to 5849. The average GA
was under 33 weeks, and average birth weight was <1900g in
included studies.
In 23 studies reporting IVH as outcome for preterm infants, 10
studies reported mild IVH (grade I and II); 14 studies reported
severe IVH (grade III and IV), 11 studies did not report
information regarding the grades of IVH. Twenty-one studies
reported data on chorioamnionitis. Two studies reported data on
ureaplasma. The characteristics of the included studies are shown
in Table 1.
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Figure 1. Flow diagram showing the results of search strategy.
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All the studies in the meta-analysis were cohort studies. Based on
our assessment, 11 studies[18,23,30,31,33,35,37–39,44,49] were rated
as high-quality studies (scores of 9), and 12 studies[28,32,34,36,40–
43,45–48] were rated as low-quality studies (scores of 7–8)
(Table 2).3.3. Antenatal infection and IVH
Evaluating all 23 of the studies, the overall effect sizes for IVH
were signiﬁcantly different (OR 2.18, 95% CI 1.58–2.99) (23
trials/12693 infants) between those with and without antenatal
infection, indicating that antenatal infections increase the risk of
IVH in preterm infants (Fig. 2). Additionally, antenatal infection
increased not only the risk of mild IVH (OR 1.95, 95% CI 1.09–33.49) (11 trials/3028 infants), but also severe IVH (OR 2.65,
95% CI 1.52–4.61) (14 trials/5484 infants) in premature infants
(Fig. 3A and B).
To determine whether the type of infection is associated
with IVH, we conducted subgroup analyses of different types
of antenatal infection. Seventeen of the studies assessed the
impact of histologic chorioamnionitis and found it increases the
risk of IVH (OR 2.26 95% CI 1.55–3.28) (19 trials/10754
infants). In addition, IVH (OR1.88, 95%CI 1.22–2.92) (2 trials/
2562 infants) was statistically signiﬁcantly increased in the
babieswhosemothers had clinical chorioamnionitis. TheORand
95% CI was 1.88 (1.14–3.10) (2 trials/484 infants) for
ureaplasma (Fig. 3C and D). The ﬁxed-effects model was
selected for subgroup of ureaplasma because of the I2=0% and
P= .51. For the other group, the random-effects model was
selected.
Table 1
Characteristics of included studies.
Author Year Country
Infants
number Infection GA, wk P GA Birth weight, g Primary outcomes
Signiﬁcant
effect
Granger et al[23] 2018 Australia 212 HCA 29.8±3.6 No info 1505±728 PVL; abnormal white matter signal No
No 32.2±3.2 1686±588
Xie et al[30] 2017 China 151 HCA+ funisitis 31.1±1.7 <.05 1685.6±386.9 RDS; BPD; NEC; ROP Yes
∗
HCA 31.7±1.8 1814.9±430.5
No 31.9±1.2 1765.2±339.5
Li[31] 2016 China 295 HCA 31.5±1.9 <.05 1730.2±424 Sepsis; BPD; RDS; NEC; PDA; death No
No 31.4±1.7 1630.6±416
Stark et al[18] 2015 Australia 83 HCA 25–29 >.05 No info PDA Yes
No 23–27 No info
Liu et al[33] 2014 China 95 MIR+FIR 219.57±10.97 (days) >.05 1688.90±392.00 BPD; RDS; NEC; PDA Yes†
MIR 220.83±11.97 (days) 1747.11±371.52
No 223.33±11.60 (days) 1692.12±443.37
Arayici et al[35] 2014 Japan 281 HCA 28.8±2.6 >.05 1138±350 RDS;EOS; PDA; NEC; BPD; mortality Yes
No 29.1±2.5 1210±299
Xu et al[37] 2012 China 88 CA 31.6±2.2 >.05 1518±441 PVL Yes
No 32.1±1.9 1559±385
Ahn et al[38] 2012 Korea 257 HCA 30.3±2.6 No info 1505±475.22 RDS;EOS; PDA; NEC; BPD; mortality Yes
No 30.8±2.34 1552.9±503.25
Kasper et al[39] 2011 Austria 238 Ureaplasma 29.4 (27.3–31.3) >.05 1235 (1030–1616) BPD; PVL; ROP Yes
No 29.9 (27.9–31.4) 1196 (939–1575)
Viscardi et al[49] 2008 USA 246 Ureaplasma 27.3±2.3 No info 951±242 BPD; PVL Yes‡
No 27.6±2.5 996±289
Sarkar et al[44] 2005 USA 62 HCA 25.9±1.5 >.05 902±262 PVL No
No 26.4±1.7 869±281
Miyazaki et al[32] 2015 Japan 5849 HCA 26.5±2.6 <.05 921±295 RDS; CLD; NEC; PDA; PVL; sepsis; mortality No
No 28.1±2.8 995±302
Ecevit et al[34] 2014 Japan 1392 HCA No info No info No info RDS; PDA; BPD; mortality; EOS; NEC; LOS No
No No info No info
Soraisham et al[36] 2013 Canada 384 HCA 26±1.5 <.05 895±226 RDS; PVL; BPD; ROP; PDA; NEC Yes
No 26.6±1.3 875±210
Shi et al[40] 2010 China 493 HCA No info No info No info RDS; PDA; BPD; mortality; EOS; LOS Yesx
No No info No info
Been et al[48] 2009 Netherlands 301 HCA+F 28.0±2.1 <.05 1142±353 RDS; PDA; BPD; death EOS; NEC; PVL Yes¶
28.7±1.9 1249±365
No 29.6±1.7 1112±339
Zanardo et al[41] 2008 Italy 287 HCA 27±2.5 <.05 1012±359 RDS; PDA; BPD; death; EOS; LOS; PVL Yes
No 30±2.3 1188±417
Rocha et al[42] 2007 Portugal 452 HCA 30 (23–33) <.05 1400 (515–2515) Sepsis; PDA; death No
No 31 (23–33) 1450 (540–2620)
Alexander et al[46] 1998 USA 1367 CCA 28.2±2.5 <.05 1120±245 RDS; PVL; death; sepsis; seizures Yes
No 28.9±2.8 1139±250
Morales[47] 1987 USA 698 HCA 29.3±1.8 >.05 1218±256 RDS; sepsis; mortality; ROP Yes
No 29.3±1.8 1137±185
Pappas et al[29] 2014 USA 2390 HCA+CCA 24.1±1.39 >.05 Unclear EOS; PVL; NEC; ROP; LOS; death Yes
HCA 24.2±1.36 Unclear
No 24.6±1.29
Richardson et al[43] 2006 Canada 494 CA 29.5±2.7 <.05 1452±466 RDS; PVL; BPD; death No
Funistis 29.4±2.6 1512±510
No 30.6±2.3 1703±487
Polam et al[45] 2005 USA 177 HCA 26.1±2.8 <.05 947±236 CLD; PVL; ROP Yes
No 27.1±1.5 966±219
BPD=bronchopulmonary dysplasia, CA= chorioamnionitis, CCA= clinical chorioamnionitis, CLD=chronic lung disease, EOS= early onset sepsis, F= fetal involvement, FIR= fetal inﬂammatory response, GA=
gestational age, HCA=histologic chorioamnionitis, IVH= intraventricular hemorrhage, LOS= late onset sepsis, MIR=maternal inﬂammatory response, NEC=necrotizing enterocolitis, PDA=patent ductus
arteriosus, PVL= cystic periventricular leukomalacia, RDS= respiratory distress syndrome, ROP= retinopathy of prematurity.
∗
Compared with HCA () funisitis (), HCA (+) funisitis (+) may increase the risk of IVH, P< .05.
† Compared with other 2 groups, MIR (+) FIR (+) increases the risk of IVH (Grade II–IV), P< .05.
‡ Compared with control groups, ureaplasma (serum PCR) increases the risk of IVH (Grade III–IV), P< .05.
x HCA (level II–III) increases the risk of IVH, 95% conﬁdence intervals were 1.33 (1.02–1.87) and 2.01 (1.54–2.73), respectively.
¶ Compared with HCA () F (), HCA (+) F (+) may increase the risk of IVH, P< .05.
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Figure 2. Forest plots of antenatal infection and intraventricular hemorrhage (IVH)
could increase the risk of IVH in preterm infant.
Table 2
Newcastle–Ottawa Quality Assessment Scale results for the
included studies.
Author Selection Comparability
Exposure/
outcome
Total
scores
Granger et al[23] 4 2 3 9
Xie et al[30] 4 2 3 9
Li et al[31] 4 2 3 9
Stark et al[18] 4 2 3 9
Liu et al[33] 4 2 3 9
Arayici et al[35] 4 2 3 9
Xu et al[37] 4 2 3 9
Ahn et al[38] 4 2 3 9
Kasper et al[39] 4 2 3 9
Viscardi et al[49] 4 2 3 9
Sarkar et al[44] 4 2 3 9
Miyazaki et al[32] 4 1 3 8
Ecevit et al[34] 4 1 3 8
Soraisham et al[36] 4 1 3 8
Shi et al[40] 4 1 3 8
Been et al[48] 4 1 3 8
Zanardo et al[41] 4 1 3 8
Rocha et al[42] 4 1 3 8
Alexander et al[46] 4 1 3 8
Morales[47] 4 1 3 8
Pappas et al[29] 4 1 2 7
Richardson et al[43] 4 1 2 7
Polam et al[45] 4 1 2 7
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53.4. Sensitivity analysis
After removing all of the low-quality studies, there were still
signiﬁcant changes in the risk of IVH (OR 1.92, 95% CI 1.35–
2.75) (11 trials/2008 infants), severe IVH (OR 2.33, 95% CI
1.45–3.74) (7 trials/1267 infants) and histologic chorioamnio-
nitis group (OR 2.14, 95% CI 1.24–3.70) (9 trials/1430 infants).
However, there were no longer statistically signiﬁcant differences
in themild IVH group (OR 1.13, 95%CI 0.75–1.70) (5 trials/729
infants). Notably, the result of ureaplasma group was not
affected because the 2 included studies were of high-quality.
There was no result for clinical chorioamnionitis because both
studies were of low quality.
When we only included articles without statistical differences
in baseline GA between infection and no infection group, there
was a signiﬁcantly increased risk for severe IVH (OR 3.04, 95%
CI 1.02–9.05) (7 trials/3380 infants), in clinical chorioamnionitis
(OR 1.57, 95% CI 1.18–2.09) (1 trial/1195 infants) and
ureaplasma group (OR 2.32, 95% CI 1.06–5.09) (1 trial/238
infants). However, no signiﬁcant differences was obsereved for
IVH (OR 2.19, 95% CI 0.81–5.95) (8 trials/3463 infants), mild
IVH (OR 1.85, 95%CI 0.40–8.48) (5 trials/1181 infants), and in
histologic chorioamnionitis group (OR 2.36, 95%CI 0.91–6.17)
(9 trials/3731 infants).3.5. Publication bias
The publication bias was ﬁrst evaluated visually by the funnel
plot (Fig. 4). Then, we performed Egger test to explore potential. Odds ratio >1 indicates that compared with noninfection, antenatal infection
Figure 3. Forest plots of antenatal infection and intraventricular hemorrhage (IVH). (A) Forest plots of antenatal infection and mild IVH. (B) Forest plots of antenatal
infection and severe IVH. (C) Forest plots of chorioamnionitis and IVH. (D) Forest plots of ureaplasma and IVH. Odds ratio >1 indicates that compared with
noninfection, antenatal infection could increase the risk of IVH in preterm infant.
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Figure 4. (A) Funnel plot of antenatal infection and intraventricular hemorrhage (IVH). (B) Funnel plot of antenatal infection and mild IVH. (C) Funnel plot of antenatal
infection and severe IVH. (D) Funnel plot of chorioamnionitis and IVH.
Huang et al. Medicine (2019) 98:31 www.md-journal.compublication bias. For the subgroups of clinical chorioamnionitis
and ureaplasma, Egger test could not be performed because of the
low number of studies. For the other group, the results showed
that the publication bias were not signiﬁcant (P> .05).
3.6. GRADE assessment
The qualities of the evidence were low for IVH (all grade) and
severe IVH, and very low for mild IVH (Fig. 5). The quality
started as low as all studies were cohort studies and that
outcomes were downgraded because of signiﬁcant heterogeneity
and upgraded by OR >2.
4. Discussion
Our meta-analysis veriﬁed the profound relationship between
antenatal infection and IVH in preterm infants from current
evidence. Our ﬁndings extend the understanding of previous
reports. The results from 23 cohort studies with 13605 infants
indicated that antenatal infection increased the incidence of IVH
in preterm infants (OR 2.18, 95% CI 1.58–2.99). The risk of
both mild (OR 1.95, 95% CI 1.09–3.49) and severe IVH (OR72.65, 95% CI 1.52–4.61) was increased by antenatal infection,
compared with no infection.
More than 50% of preterm fetuses delivered before 30 weeks’
gestation have chorioamnionitis, rather than presentations of
sepsis/pneumonia syndromes.[50] In our review, the most
frequently reported antenatal infection was chorioamnionitis.
Antenatal infection including histologic chorioamnionitis (OR
2.26 95%CI 1.55–3.28) and clinical chorioamnionitis (OR 1.88,
95% CI 1.22–2.92) contributes to the development of IVH. As
the pathogenesis of IVH is not completely known, our ﬁnding
that antenatal infection increases the risk of development of IVH
highlights a new perspective for the etiology of IVH. This may be
of beneﬁt to the prevention of this common preterm complication
by reducing antennal infection. The reported impact of antenatal
infections on IVH among preterm infants adds up to the well-
known maternal–infant interaction.4.1. Overall completeness and applicability of evidence
We have attempted to identify all available published and
unpublished data for the relationship of antenatal infection and
IVH in preterm birth. The included studies were performed in
Figure 5. Quality evaluation by GRADE tool for antenatal infection versus no infection.
Huang et al. Medicine (2019) 98:31 Medicineneonatal intensive care units in Australia, China, Japan, United
States, Canada, Netherlands, Italy, and Portugal. Data yielded
across the globe may be widely representative. Thus, the evidence
of our review is applicable to most hospital settings in mid- or
high-income countries. New evidence from low-income country
would support the overall applicability of the data. The average
GA of neonates in included studies was preterm infants <33
weeks with birth weight <1900g. Thus, these ﬁndings should be
cautiously applied to late preterm (34–36 weeks) infants. The
included studies were published from 1987 to 2018. Although
there is a large time span, the majority of studies were published
in the era of 2000s, and the diagnostic criteria for IVH have
remained constant, whichmakes the results applicable for current
practice.4.2. Advantages and limitations
Our meta-analysis has several advantages. First, this is the ﬁrst
systematic review to summarize the current evidence regarding
the relationship between antenatal infection and risk of IVH. The
severity of IVH (all grades IVH, mild IVH, and severe IVH) and
the type of antenatal infection (histologic chorioamnionitis,
clinical chorioamnionitis, and ureaplasma) were carefully
assessed. The relationship between antenatal infection and
IVH was generally supported by the statistically signiﬁcantly
effects from results of our meta-analysis. This indicates that
antenatal infection may lead to increased risk of IVH in preterm
infants. Second, meta-analyses of observational studies are prone8to biases and confounding factors owing to intrinsic nature of the
original studies. We minimized the bias by restricting our
analyses to cohort studies, and excluding traditional case–control
studies, which are prone to recall and interviewer bias. Third,
sensitivity analysis provides robust evidence for the association in
this review. Results were generally consistent when we applied
sensitivity analysis. Most of the sensitivity analysis results have
not changed signiﬁcantly after discarding low-quality studies.
Fouth, the results of funnel plot and Egger test showed no
signiﬁcant publication bias, whichmeans the results have low risk
of selection bias. Finally, our meta-analysis included studies from
different countries and the preterm infants included in the studies
ranged from extremely low borth weight to LBW, indicating that
our ﬁndings are broadly representative.
Our study has some limitations. First of all, all of the included
studies were observational studies, which may be inﬂuenced by
selection bias. The quality of the evidence was graded as “low or
very low,” because of entirely of observational studies design and
high heterogeneity. However, the relationship between antenatal
infection and IVH cannot be investigated in RCTs for ethical or
methodological reasons. Observational research is useful for
assessing etiology and is the only choice for this topic to provide
evidence for clinical decision. In addition, we restricted our search
to English and Chinese databases. Research published in other
language was not included. This may lead to selection bias from
language.
One important issue is the complicated relationship among
infection, prematurity, and IVH. It is well known that a lower GA
Huang et al. Medicine (2019) 98:31 www.md-journal.comis associated with a higher frequency of IVH. Besides,
chorioamnionitis is much more frequent in low GA. In this
review, some included studies had a signiﬁcant GA difference
between the infection and noninfection group. To assess possible
impact of antenatal infection on IVH through GA, we performed
sensitivity analysis by eliminating studies with signiﬁcant GA
difference. We found there was a signiﬁcant increased risk for
severe IVH, in the clinical chorioamnionitis and ureaplasma
group. Increased trends were obsereved for IVH, mild IVH, and
in the histologic chorioamnionitis group, although there were no
statistically signiﬁcant differences. These outcomes may indicate
that antenatal infection leads to IVH not only based on lower GA.4.3. Implications for practice and research
It has been reported that routine use of an antenatal infection
screen and treat program could decrease the risk of preterm
birth.[3] Given the evidence between antenatal infection and IVH,
researchers should carefully consider the need of antenatal
infection screen and treat program for IVH in the future
researches, which may prevent the preterm infant from avoidable
IVH.5. Conclusion
In conclusion, we found that antenatal infection may play an
important role in predisposing preterm newborns to IVH and we
stress the importance of antenatal infection prevention. Our
meta-analysis was limited by the low or very low quality of
evidence of GRADE assessment, indicating that additional well-
designed studies should be performed to explore the role of
antenatal infections in IVH.Author contributions
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